The company's financial performance shows improvement, with increased revenue, EBITDA, and net income. There is a clear strategy for growth with new bed onboarding and expansion plans. The Q&A reveals active pursuit of growth opportunities, though some responses lack specificity. Overall, the strong financial results and strategic initiatives suggest a positive outlook, likely leading to a stock price increase of 2% to 8%.